• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

30/05/2025 20:43

ANG Lifesciences Ind - Board Meeting Outcome for Outcome Of Board Meeting

Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that at the Board Meeting held today i.e. on Friday, 30th May, 2025, and have Considered and approved the Audited Standalone and Consolidated Financial Results for the Quarter and Financial Year ended 31st March, 2025. The said Audited Financial Results were reviewed by Audit Committee and thereafter approved by the Board of Directors.\r\n\r\n